FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131785306> ?p ?o ?g. }

• W2131785306 endingPage "411" @default.
• W2131785306 startingPage "381" @default.
• W2131785306 abstract "Background: Kanglaite (KLT) is a botanically sourced, molecularly targeted agent that is prepared as a microemulsion for IV use. The active substance is extracted from the herb Semen coicis. Objective: The aim of this study was to evaluate the effectiveness and tolerability of KLT injection in patients with primary non-small cell lung cancer (NSCLC). Methods: We electronically searched the literature of the China National Knowledge Infrastructure (Chinese language, 1979-March 2008), CBMdisc (Chinese, 1978-March 2008), The Cochrane Library (English, Issue 4, 2007), MEDLINE (English, 1966-March 2008), and EMBASE (English, 1984-March 2008), and manually searched 20 Chinese-language oncology journals to identify randomized controlled trials (RCTs) of KLT injection plus chemotherapy versus chemotherapy alone, regardless of their having been published or not, blinding, duration of treatment, or duration of follow-up. The quality of the included trials was assessed using the method recommended by The Cochrane Collaboration. The studies were assigned to 1 of the following 3 categories: A = all quality criteria met, low risk of bias; B = ≥1 of the quality criteria only partially met, moderate risk of bias; or C = ≥1 of the quality criteria not met, high risk of bias. If heterogeneity existed among subgroups, then overall results were calculated based on a random-effects model; otherwise, a fixed-effects model was used. Results: Electronic database searches yielded 596 citations. A title review eliminated 377 manuscripts; 219 citations were marked for further evaluation. Finally, we identified 26 trials that met the inclusion and exclusion criteria. The 26 RCTs included in this meta-analysis included 2209 patients with NSCLC; no study was graded A, 9 were graded B, and 17 were graded C. The sample size of each trial varied from 40 to 305 patients; none of the trials had precalculated sample sizes. Pooled analyses performed using both fixed- and random-effects models revealed that compared with chemotherapy alone, KLT injection plus chemotherapy improved the response rate (relative risk [RR], 1.34; 95% CI, 1.19–1.51 and RR, 1.35; 95% CI, 1.20–1.51, respectively) and quality of life as measured by an increase ≥10 points in the Karnofsky Performance Status score (RR, 2.05; 95% CI, 1.60–2.64). KLT injection plus chemotherapy was associated with improvement in the symptoms of cough, dyspnea, chest pain, fatigue, and anorexia. KLT injection plus chemotherapy was also associated with significant reduction in the incidence of the following adverse events (AEs) based on the fixed and random effects models, respectively: grade II to IV leukopenia (RR, 0.29; 95% CI, 0.22–0.39 and RR, 0.33; 95% CI, 0.22–0.48), anemia (RR, 0.54; 95% CI, 0.42–0.70 and RR, 0.55; 95% CI, 0.40–0.76), thrombocytopenia (RR, 0.39; 95% CI, 0.21–0.71 and RR, 0.40; 95% CI, 0.21–0.78), nausea and vomiting (RR, 0.44; 95% CI, 0.34–0.57 and RR, 0.44; 95% CI, 0.35–0.57), phlebitis (RR, 3.44; 95% Cl, 1.30–9.15 and RR, 3.38; 95% CI, 1.28–8.89), and hepatic dysfunction (RR, 0.44; 95% CI, 0.15–1.35 and RR, 0.44; 95% CI, 0.24–0.81). Conclusion: This meta-analysis found that KLT injection in combination with chemotherapy was associated with improved response rate, quality of life, and symptoms, and a reduced incidence of AEs compared with chemotherapy alone in patients with NSCLC. These findings should be viewed with caution because of the low quality of the included trials." @default.
• W2131785306 created "2016-06-24" @default.
• W2131785306 creator A5030169080 @default.
• W2131785306 creator A5030921116 @default.
• W2131785306 creator A5040327147 @default.
• W2131785306 creator A5042945387 @default.
• W2131785306 creator A5070996678 @default.
• W2131785306 date "2008-10-01" @default.
• W2131785306 modified "2023-10-18" @default.
• W2131785306 title "Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis" @default.
• W2131785306 cites W2137051656 @default.
• W2131785306 cites W2157118246 @default.
• W2131785306 cites W2167805334 @default.
• W2131785306 doi "https://doi.org/10.1016/j.curtheres.2008.10.004" @default.
• W2131785306 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3969920" @default.
• W2131785306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24692815" @default.
• W2131785306 hasPublicationYear "2008" @default.
• W2131785306 type Work @default.
• W2131785306 sameAs 2131785306 @default.
• W2131785306 citedByCount "25" @default.
• W2131785306 countsByYear W21317853062015 @default.
• W2131785306 countsByYear W21317853062016 @default.
• W2131785306 countsByYear W21317853062017 @default.
• W2131785306 countsByYear W21317853062018 @default.
• W2131785306 countsByYear W21317853062019 @default.
• W2131785306 countsByYear W21317853062020 @default.
• W2131785306 countsByYear W21317853062021 @default.
• W2131785306 countsByYear W21317853062022 @default.
• W2131785306 countsByYear W21317853062023 @default.
• W2131785306 crossrefType "journal-article" @default.
• W2131785306 hasAuthorship W2131785306A5030169080 @default.
• W2131785306 hasAuthorship W2131785306A5030921116 @default.
• W2131785306 hasAuthorship W2131785306A5040327147 @default.
• W2131785306 hasAuthorship W2131785306A5042945387 @default.
• W2131785306 hasAuthorship W2131785306A5070996678 @default.
• W2131785306 hasBestOaLocation W21317853061 @default.
• W2131785306 hasConcept C126322002 @default.
• W2131785306 hasConcept C142724271 @default.
• W2131785306 hasConcept C143998085 @default.
• W2131785306 hasConcept C168563851 @default.
• W2131785306 hasConcept C17744445 @default.
• W2131785306 hasConcept C197934379 @default.
• W2131785306 hasConcept C199539241 @default.
• W2131785306 hasConcept C204787440 @default.
• W2131785306 hasConcept C2771230 @default.
• W2131785306 hasConcept C2776256026 @default.
• W2131785306 hasConcept C2776478404 @default.
• W2131785306 hasConcept C2776694085 @default.
• W2131785306 hasConcept C2777596629 @default.
• W2131785306 hasConcept C2778375690 @default.
• W2131785306 hasConcept C2779473830 @default.
• W2131785306 hasConcept C71924100 @default.
• W2131785306 hasConcept C95190672 @default.
• W2131785306 hasConceptScore W2131785306C126322002 @default.
• W2131785306 hasConceptScore W2131785306C142724271 @default.
• W2131785306 hasConceptScore W2131785306C143998085 @default.
• W2131785306 hasConceptScore W2131785306C168563851 @default.
• W2131785306 hasConceptScore W2131785306C17744445 @default.
• W2131785306 hasConceptScore W2131785306C197934379 @default.
• W2131785306 hasConceptScore W2131785306C199539241 @default.
• W2131785306 hasConceptScore W2131785306C204787440 @default.
• W2131785306 hasConceptScore W2131785306C2771230 @default.
• W2131785306 hasConceptScore W2131785306C2776256026 @default.
• W2131785306 hasConceptScore W2131785306C2776478404 @default.
• W2131785306 hasConceptScore W2131785306C2776694085 @default.
• W2131785306 hasConceptScore W2131785306C2777596629 @default.
• W2131785306 hasConceptScore W2131785306C2778375690 @default.
• W2131785306 hasConceptScore W2131785306C2779473830 @default.
• W2131785306 hasConceptScore W2131785306C71924100 @default.
• W2131785306 hasConceptScore W2131785306C95190672 @default.
• W2131785306 hasIssue "5" @default.
• W2131785306 hasLocation W21317853061 @default.
• W2131785306 hasLocation W21317853062 @default.
• W2131785306 hasLocation W21317853063 @default.
• W2131785306 hasLocation W21317853064 @default.
• W2131785306 hasOpenAccess W2131785306 @default.
• W2131785306 hasPrimaryLocation W21317853061 @default.
• W2131785306 hasRelatedWork W1967911880 @default.
• W2131785306 hasRelatedWork W2354407060 @default.
• W2131785306 hasRelatedWork W2377958650 @default.
• W2131785306 hasRelatedWork W2381982637 @default.
• W2131785306 hasRelatedWork W2914141471 @default.
• W2131785306 hasRelatedWork W3013041320 @default.
• W2131785306 hasRelatedWork W3091070573 @default.
• W2131785306 hasRelatedWork W3096683796 @default.
• W2131785306 hasRelatedWork W3152374296 @default.
• W2131785306 hasRelatedWork W4306167665 @default.
• W2131785306 hasVolume "69" @default.
• W2131785306 isParatext "false" @default.
• W2131785306 isRetracted "false" @default.
• W2131785306 magId "2131785306" @default.
• W2131785306 workType "article" @default.